JP2014098037A5 - - Google Patents

Download PDF

Info

Publication number
JP2014098037A5
JP2014098037A5 JP2014037949A JP2014037949A JP2014098037A5 JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5 JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5
Authority
JP
Japan
Prior art keywords
formulation
infection
tissue
sodium
dichlorotaurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014037949A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014098037A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014098037A publication Critical patent/JP2014098037A/ja
Publication of JP2014098037A5 publication Critical patent/JP2014098037A5/ja
Withdrawn legal-status Critical Current

Links

JP2014037949A 2007-05-01 2014-02-28 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸 Withdrawn JP2014098037A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01
US60/915,271 2007-05-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010506585A Division JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Publications (2)

Publication Number Publication Date
JP2014098037A JP2014098037A (ja) 2014-05-29
JP2014098037A5 true JP2014098037A5 (OSRAM) 2014-08-07

Family

ID=39616420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010506585A Withdrawn JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸
JP2014037949A Withdrawn JP2014098037A (ja) 2007-05-01 2014-02-28 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010506585A Withdrawn JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Country Status (17)

Country Link
US (2) US20080275126A1 (OSRAM)
EP (1) EP2139520B1 (OSRAM)
JP (2) JP2010526084A (OSRAM)
KR (1) KR20100017156A (OSRAM)
CN (1) CN101678105A (OSRAM)
AR (1) AR066371A1 (OSRAM)
AU (1) AU2008245460B2 (OSRAM)
BR (1) BRPI0811073A2 (OSRAM)
CA (1) CA2684101A1 (OSRAM)
CL (1) CL2008001283A1 (OSRAM)
ES (1) ES2432408T3 (OSRAM)
MX (1) MX2009011817A (OSRAM)
RU (1) RU2009144291A (OSRAM)
TW (1) TW200902092A (OSRAM)
UY (1) UY31057A1 (OSRAM)
WO (1) WO2008134692A1 (OSRAM)
ZA (1) ZA200907052B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009126912A1 (en) * 2008-04-10 2009-10-15 Novabay Pharmaceuticals, Inc. Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
US20110091570A1 (en) * 2008-04-15 2011-04-21 Waldemar Gottardi Compositions and Devices for Antisepsis and Anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
WO1996003158A1 (en) * 1994-07-22 1996-02-08 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
EP1469860A4 (en) * 2002-01-24 2005-09-07 Yissum Res Dev Co ANTICANCER COMBINATION AND USE THEREOF
BRPI0413660A (pt) * 2003-08-18 2006-10-24 Novacal Pharmaceuticals Inc Aminoácidos n,n-di-alogenado e derivados
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
EP1948154A1 (en) * 2005-10-06 2008-07-30 Novabay Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids

Similar Documents

Publication Publication Date Title
AR118371A2 (es) Procedimiento para la preparación de n-[(3-aminooxetan-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepin-4-il)-6-metil-quinazolin-4-amina
LT3672954T (lt) Junginiai, jų druskos ir jų naudojimas ligoms gydyti
PL3556377T3 (pl) Dalargin do stosowania w leczeniu ostrych infekcji wirusowych dróg oddechowych
JP2011516477A5 (OSRAM)
IL272314A (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
LT3890767T (lt) Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui
MX2017012272A (es) Solucion para inhalacion de tiotropio para nebulizacion.
HUE044731T2 (hu) Formulációk a száj, torok és respiratorikus traktus rendellenességeinek kezelésére
EP3927428A4 (en) METHODS OF TREATMENT OF RESPIRATORY DISEASES
SG11201702766YA (en) Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (rsv)
FI3248597T3 (fi) Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen
NZ753749A (en) Treatment of respiratory tract diseases and infections with glutathione compositions
JP2014098037A5 (OSRAM)
EP4132547A4 (en) ALKALINE RESPIRATORY EPITHELIUM THERAPY TO TREAT VIRAL RESPIRATORY INFECTION
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
EA201592298A1 (ru) Полуживая вирусная вакцина против респираторно-синцитиального вируса
JP2012508693A5 (OSRAM)
JP2015508052A5 (OSRAM)
WO2018085516A3 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
EA201592299A1 (ru) Полуживая вирусная вакцина против респираторно-синцитиального вируса
WO2016072854A3 (en) Pantothenamide analogues
EP3612178A4 (en) VASODILATERS FOR THE TREATMENT OF HEART FAILURE
EP3322481A4 (en) TREATMENT OF ROTATOR COIL DRESSES
NZ713490A (en) Oral suspension for treating eosinophilic esophagitis
AU2017905124A0 (en) Treatment of respiratory infection (2)